<DOC>
	<DOCNO>NCT02795390</DOCNO>
	<brief_summary>It double-blinded , randomize , placebo-controlled trial advance cancer patient response current laxatives treatment . 60 patient randomly assign individualize herbal intervention ( treatment group ) placebo ( control group ) 1:1 ratio . For treatment group , MaZiRenWan 10g plus HuangQi 20g chosen core prescription . Furthermore , two six herbal granule add accord syndrome differentiate individual participant . Placebo make dextrin ( 76.03 % ) , tea essence ( 23.61 % ) , gardenin ( 0.02 % ) , caramel ( 0.34 % ) achieve color , smell , taste , texture comparable herbal granule . Patients instructed dissolve granule 150ml hot water , twice daily two week . The primary end point global symptom improvement . Secondary outcome measure include stool frequency , stool form , use rescue herbal granule , constipation visual analogue scale ( CVAS ) ( 0=none 7=most severe ) individual assessment constipation relate symptom . For safety profile herbal intervention , important adverse event report clinical laboratory evaluation liver renal function determine .</brief_summary>
	<brief_title>Clinical Trial Palliative Cancer Patients With Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>Severity constipation &gt; 3 point ( 8point scale 0 7 ) Palliative Performance Scale â‰¥60 % Relatively stable liver renal function within 3 month Patients read speak Chinese Inability communicate Presence colostomy , gastrointestinal obstruction Presence loose watery stool ( Bristol stool scale 67 ) bowel movement &gt; 3/day routine laxative treatment History Chinese herbal medicine allergy Estimated life expectancy le 1 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Chinese herbal medicine</keyword>
	<keyword>Placebo</keyword>
	<keyword>Randomized control trial</keyword>
	<keyword>Constipation</keyword>
</DOC>